Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.

Martin RM, Turner EL, Young GJ, Metcalfe C, Walsh EI, Lane JA, Sterne JAC, Noble S, Holding P, Ben-Shlomo Y, Williams NJ, Pashayan N, Bui MN, Albertsen PC, Seibert TM, Zietman AL, Oxley J, Adolfsson J, Mason MD, Davey Smith G, Neal DE, Hamdy FC, Donovan JL, CAP Trial Group

Open source

DOI: 10.1001/jama.2024.4011
Published: 2024 May 7
Container: JAMA
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2024.4011,
  title = {Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.},
  author = {Martin RM and Turner EL and Young GJ and Metcalfe C and Walsh EI and Lane JA and Sterne JAC and Noble S and Holding P and Ben-Shlomo Y and Williams NJ and Pashayan N and Bui MN and Albertsen PC and Seibert TM and Zietman AL and Oxley J and Adolfsson J and Mason MD and Davey Smith G and Neal DE and Hamdy FC and Donovan JL and CAP Trial Group},
  year = {2024},
  journal = {JAMA},
  doi = {10.1001/jama.2024.4011},
  url = {https://doi.org/10.1001/jama.2024.4011}
}

RIS

TY  - JOUR
TI  - Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
AU  - Martin RM
AU  - Turner EL
AU  - Young GJ
AU  - Metcalfe C
AU  - Walsh EI
AU  - Lane JA
AU  - Sterne JAC
AU  - Noble S
AU  - Holding P
AU  - Ben-Shlomo Y
AU  - Williams NJ
AU  - Pashayan N
AU  - Bui MN
AU  - Albertsen PC
AU  - Seibert TM
AU  - Zietman AL
AU  - Oxley J
AU  - Adolfsson J
AU  - Mason MD
AU  - Davey Smith G
AU  - Neal DE
AU  - Hamdy FC
AU  - Donovan JL
AU  - CAP Trial Group
PY  - 2024
JO  - JAMA
DO  - 10.1001/jama.2024.4011
UR  - https://doi.org/10.1001/jama.2024.4011
ER  -

APA

RM, M., EL, T., GJ, Y., C, M., EI, W., JA, L., JAC, S., S, N., P, H., Y, B., NJ, W., N, P., MN, B., PC, A., TM, S., AL, Z., J, O., J, A., MD, M., G, D. S., DE, N., FC, H., JL, D., & Group, C. T. (2024). Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2024.4011

Source records

pubmed · retrieved 2026-09-26T16:42:37.669Z